Intramedullary tuberculoma during infliximab therapy.
Ottaviani
Sébastien
S
Department of Rheumatology, University Diderot Paris-7, APHP Bichat Claude Bernard Hospital, Paris, France. sebastien.ottaviani@lrb.aphp.fr
Meyer
Olivier
O
Dieudé
Philippe
P
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D009894:Opportunistic Infections / Q000276:immunology*; D014375:Tuberculoma / Q000276:immunology*; D014391:Tuberculosis, Miliary / Q000276:immunology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab